Back to search
FDAFDA · Food and drugs·Recall number D-0445-2025

Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01.

Published May 28, 2025 · Recall initiated: May 9, 2025

Summary

FDA records drug Class II recall D-0445-2025, published May 28, 2025 and initiated May 9, 2025. Recalling firm: KVK Tech, Inc.; Status: Ongoing; Reported quantity: 9107 bottles; Lot: Lot#: 18400A, Exp 7/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP deviations

What to do

Voluntary: Firm initiated · E-Mail

Get an email if INDOMETHACIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
INDOMETHACIN
Manufacturer
KVK Tech, Inc.
Distributor
Nationwide
UPC
0310702016101
Lot
Lot#: 18400A, Exp 7/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 18940, Made in USA, NDC 10702-016-01. recalled?

Yes. FDA published recall D-0445-2025 on May 28, 2025. Reported hazard: cGMP deviations

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: INDOMETHACIN. UPC: 0310702016101.